| 发明名称 |
COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF ELETRIPTAN |
| 摘要 |
The bioavailabilty of eletriptan can be increased by co-administering eletriptan with a p-glycoprotein (p-gp) inhibitor. The eletriptan and p-gp inhibitor can be administered together in a composition or as separate components. If administered separately, they can be embodied as a kit. |
| 申请公布号 |
WO02070070(A3) |
申请公布日期 |
2003.04.10 |
| 申请号 |
WO2002IB00512 |
申请日期 |
2002.02.20 |
| 申请人 |
PFIZER LIMITED;HUMPHREY, MICHAEL, JOHN;PFIZER, INC. |
发明人 |
HUMPHREY, MICHAEL, JOHN |
| 分类号 |
A61K45/00;A61K31/40;A61K31/404;A61K45/06;A61K47/10;A61K47/14;A61K47/22;A61K47/44;A61P25/06;A61P43/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
